Similar articles

• [Consensus on integrative medical diagnosis and treatment of non-alcoholic fatty liver disease].

  Specialty Committee of Digestive Diseases; Chinese Association of Integrative Medicine. Specialty Committee of Digestive Diseases, et al. Zhongguo Zhong Xi Yi Jie He Za Zhi. 2011 Feb;31(2):155-8. Zhongguo Zhong Xi Yi Jie He Za Zhi. 2011. PMID: 21425564 Chinese. No abstract available.
• [The key target of Chinese medicine treatment on alcoholic and nonalcoholic fatty liver disease: the gut].

  Hu YY, Peng JH, Feng Q. Hu YY, et al. Zhongguo Zhong Xi Yi Jie He Za Zhi. 2011 Sep;31(9):1269-72. Zhongguo Zhong Xi Yi Jie He Za Zhi. 2011. PMID: 22013810 Chinese.
• Phase II clinical trial of phlebotomy for non-alcoholic fatty liver disease.

  Beaton MD, Chakrabarti S, Levstik M, Speechley M, Marotta P, Adams P. Beaton MD, et al. Aliment Pharmacol Ther. 2013 Apr;37(7):720-9. doi: 10.1111/apt.12255. Epub 2013 Feb 26. Aliment Pharmacol Ther. 2013. PMID: 23441892 Clinical Trial.
• Non-alcoholic fatty liver disease: an emerging liver disease in Taiwan.

  Hsu CS, Kao JH. Hsu CS, et al. J Formos Med Assoc. 2012 Oct;111(10):527-35. doi: 10.1016/j.jfma.2012.07.002. Epub 2012 Aug 11. J Formos Med Assoc. 2012. PMID: 23089687 Review.
• Treatment of patients with non-alcoholic fatty liver disease: current views and perspectives.

  Federico A, Trappoliere M, Loguercio C. Federico A, et al. Dig Liver Dis. 2006 Nov;38(11):789-801. doi: 10.1016/j.dld.2006.04.009. Epub 2006 Jun 5. Dig Liver Dis. 2006. PMID: 16750661 Review.